Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing PEGASYS Treatment in HBeAg Positive CHB
NCT01086085Phase 4Completed
- Sponsor
- Roche
- Start
- Apr 2010
- Primary completion
- Mar 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Roche. Started Apr 2010; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01086085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01086085.